(Q31857384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Predictive factors in radiotherapy for non-small cell lung cancer: present status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

3 November 2019

main subject

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Flentjie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Kellokumpu-Lehtinen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Zamboglou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Kosmidis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

43-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Preliminary studies on the natural history of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCL

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Three-dimensional treatment planning for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Role of positron emission tomography in the staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Volume and dose parameters for survival of non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Biologic basis for altered fractionation schemes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Evaluation of Rapid Radiation Treatment Schedules Utilizing Two Treatment Sessions per Day

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

[CHARTWEL-Bronchus (ARO 97-1): a randomized multicenter trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-call bronchial carcinoma]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

The current state of intraoperative interstitial brachytherapy in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Clinical experiences with intraoperative radiotherapy of locally advanced cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Optimization of intensity-modulated 3D conformal treatment plans based on biological indices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Potential clinical efficacy of intensity-modulated conformal therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Molecular genetic characteristics of lung cancer--useful as real' tumor markers?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Combined modality treatment with radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Tumor volume: a basic and specific response predictor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A comparison between combined neutron- and telecobalt-therapy with telecobalt-therapy alone for cancer of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964–1976

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Misonidazole—A drug for trial in radiotherapy and oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A histopathologic study on the effects of radiofrequency thermotherapy on malignant tumors of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Towards prediction and modulation of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

The use of magnetic resonance imaging and spectroscopy in the assessment of patients with head and neck and other superficial human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900156-2

7 January 2021

10.1016/S0169-5002(00)00156-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11162866%20AND%20SRC:MED&resulttype=core&format=json